Vitrolife Forecast, price target & analysts
Vitrolife Target price 2025 - Analyst rating & recommendation
Vitrolife Classifications & Recommendation:
Vitrolife Price Target
| Target Price | kr177.48 |
| Price | kr137.90 |
| Potential |
28.70%
register free of charge
|
| Number of Estimates | 7 |
|
7 Analysts have issued a price target Vitrolife 2026 .
The average Vitrolife target price is kr177.48.
This is
28.70%
register free of charge
kr241.50
75.13%
register free of charge
kr161.60
17.19%
register free of charge
|
|
| A rating was issued by 10 analysts: 8 Analysts recommend Vitrolife to buy, 2 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Vitrolife stock has an average upside potential 2026 of
28.70%
register free of charge
|
Sales and Margin forecast 2025, 2026 to 2028
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Billion kr | 3.61 | 3.54 |
| 2.76% | 2.00% | |
| EBITDA Margin | 29.26% | 30.05% |
| 5.18% | 2.70% | |
| Net Margin | 14.21% | 12.62% |
| 112.96% | 11.22% |
7 Analysts have issued a sales forecast Vitrolife 2025 . The average Vitrolife sales estimate is
This results in the following potential growth metrics:
7 Analysts have issued an Vitrolife EBITDA forecast 2025. The average Vitrolife EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
7 Vitrolife Analysts have issued a net profit forecast 2025. The average Vitrolife net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2028
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share kr | 3.79 | 3.30 |
| 113.33% | 12.93% | |
| P/E | 41.82 | |
| EV/Sales | 5.53 |
7 Analysts have issued a Vitrolife forecast for earnings per share. The average Vitrolife EPS is
This results in the following potential growth metrics and future valuations:
Current Vitrolife Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| DNB CARNEGIE |
Locked
➜
Locked
|
Locked | Dec 09 2025 |
| HANDELSBANKEN CAPITAL MARKETS |
Locked
➜
Locked
|
Locked | Oct 24 2025 |
| HANDELSBANKEN CAPITAL MARKETS |
Locked
➜
Locked
|
Locked | Jul 21 2025 |
| HANDELSBANKEN CAPITAL MARKETS |
Locked
➜
Locked
|
Locked | Jul 02 2025 |
| HANDELSBANKEN CAPITAL MARKETS |
Locked
➜
Locked
|
Locked | Jul 01 2025 |
| DNB CARNEGIE |
Locked
➜
Locked
|
Locked | Apr 24 2025 |
| DNB CARNEGIE |
Locked
➜
Locked
|
Locked | Apr 23 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
DNB CARNEGIE:
Locked
➜
Locked
|
Dec 09 2025 |
|
Locked
HANDELSBANKEN CAPITAL MARKETS:
Locked
➜
Locked
|
Oct 24 2025 |
|
Locked
HANDELSBANKEN CAPITAL MARKETS:
Locked
➜
Locked
|
Jul 21 2025 |
|
Locked
HANDELSBANKEN CAPITAL MARKETS:
Locked
➜
Locked
|
Jul 02 2025 |
|
Locked
HANDELSBANKEN CAPITAL MARKETS:
Locked
➜
Locked
|
Jul 01 2025 |
|
Locked
DNB CARNEGIE:
Locked
➜
Locked
|
Apr 24 2025 |
|
Locked
DNB CARNEGIE:
Locked
➜
Locked
|
Apr 23 2025 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
